跳至主要内容
临床试验/IRCT20200422047168N2
IRCT20200422047168N2招募中2 期

A randomized clinical trial study, comparison of the therapeutic effects of Ivermectin, Kaletra and Chloroquine with Kaletra and Chloroquine in the treatment of patients with coronavirus 2019 (COVID-19)

Ahvaz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • People over 18 years old
  • Real-time PCR test results for SARS-CoV-2 virus were positive after sampling (nasopharynx and oropharynx swab samples)
  • The manifestations of virus pneumonia in CT scans of their lungs were quite obvious.
  • Their O2 Saturation percentage were 93% or lower

排除标准

  • History of renal failure
  • Taking drugs that interfere with Ivermectin
  • Patients who have been admitted to other clinical trials

研究者

相似试验